Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UNIPROT:P42345 (
mTOR
)
26,049
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
P-
Rex
proteins are Rho/Rac guanine nucleotide exchange factors that participate in the regulation of several cancer-related cellular functions such as proliferation, motility, and invasion. Expectedly, a significant portion of these actions of P-
Rex
proteins must be related to their Rac regulatory properties. In addition, P-
Rex
proteins control signaling by the phosphoinositide 3-kinase (PI3K) route by interacting with PTEN and
mTOR
. The interaction with PTEN inhibits its phosphatase activity, leading to AKT activation. The interaction with
mTOR
may be important in nutrient-stimulated Rac activation and migration. In humans, several studies have implicated P-
Rex
proteins in the pathophysiology of various neoplasias. Thus, overexpression of P-
Rex
proteins has been linked to poor patient outcome in breast cancer and may facilitate metastatic dissemination of prostate cancer cells. In addition, whole-genome sequencing described P-Rex2 as a significantly mutated gene in melanoma. Furthermore, expression in melanocytes of mutated forms of P-Rex2 found in patients with melanoma showed the protumorigenic role of these P-
Rex
mutations in melanoma genesis. These findings open interesting opportunities for P-
Rex
targeting in cancer. Moreover, the implication of P-
Rex
partner proteins such as Rac,
mTOR
, or PTEN in cancer has opened the possibility of acting on P-
Rex
to restrict protumorigenic signaling through these pathways.
...
PMID:Molecular pathways: P-Rex in cancer. 2375 21